Tag Archives: Should

Truvada, not Descovy, should be the first choice for PrEP, US experts say

Although there are now two drug combinations which can be used for HIV prevention as PrEP, there is stronger and broader evidence for the older combination (Truvada), which should remain the first-line choice, four leading US doctors argue in the Annals of Internal Medicine today. The authors emphasise the excellent safety profile of both drugs.… Read More »

What You Should Know About Breast Cancer

Chances are you know someone who’s dealing with breast cancer and unfortunately, that’s not surprising. Breast cancer is the most common cancer diagnosis for women worldwide, accounting for 1/4 of all cancers diagnosed (1). October is breast cancer awareness month so I’d like to take some time to share information that’s easy to understand from… Read More »